Trademark: 97039740
Word
PANAVANCE
Status
Pending
Status Code
732
Status Date
Thursday, November 30, 2023
Serial Number
97039740
Mark Type
4000
Filing Date
Wednesday, September 22, 2021
Published for Opposition
Tuesday, May 3, 2022

Trademark Owner History
PANAVANCE THERAPEUTICS INC. - Owner At Publication
Panavant Therapeutics Inc. - Original Applicant

Classifications
5 Pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders
44 Providing information in the field of prevention, screening, diagnosis and treatment of oncological diseases and disorders

Trademark Events
Dec 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2023
Sou Extension 3 Granted
Nov 30, 2023
Sou Extension 3 Filed
Nov 30, 2023
Sou Teas Extension Received
Jun 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 20, 2023
Sou Extension 2 Granted
Jun 20, 2023
Sou Extension 2 Filed
Jun 20, 2023
Sou Teas Extension Received
Dec 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 2, 2022
Sou Extension 1 Granted
Dec 2, 2022
Sou Extension 1 Filed
Dec 2, 2022
Sou Teas Extension Received
Jun 28, 2022
Noa E-Mailed - Sou Required From Applicant
May 3, 2022
Official Gazette Publication Confirmation E-Mailed
May 3, 2022
Published For Opposition
Apr 13, 2022
Notification Of Notice Of Publication E-Mailed
Mar 27, 2022
Assigned To Lie
Mar 24, 2022
Approved For Pub - Principal Register
Mar 24, 2022
Examiner's Amendment Entered
Mar 24, 2022
Notification Of Examiners Amendment E-Mailed
Mar 24, 2022
Examiners Amendment E-Mailed
Mar 24, 2022
Examiners Amendment -Written
Mar 10, 2022
Assigned To Examiner
Jan 26, 2022
Automatic Update Of Assignment Of Ownership
Oct 25, 2021
New Application Office Supplied Data Entered
Sep 25, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24